An insight into artificial intelligence in drug discovery: an interview with Professor Gisbert Schneider. | Expert Opin Drug Discov;16(9): 933-935, 2021 09. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

An insight into artificial intelligence in drug discovery: an interview with Professor Gisbert Schneider.

Schneider, Gisbert.

Schneider G; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.

Expert Opin Drug Discov ; 16(9): 933-935, 2021 09.

Article in English | MEDLINE | ID: covidwho-1434303

Subject(s)

Artificial Intelligence; Drug Discovery; Humans; Quantitative Structure-Activity Relationship

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Artificial Intelligence / Drug Discovery Limits: Humans Language: English Journal: Expert Opin Drug Discov Year: 2021 Document Type: Article Affiliation country: 17460441.2021.1976007

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Artificial Intelligence / Drug Discovery Limits: Humans Language: English Journal: Expert Opin Drug Discov Year: 2021 Document Type: Article Affiliation country: 17460441.2021.1976007